Viewing StudyNCT06351592



Ignite Creation Date: 2024-05-06 @ 8:22 PM
Last Modification Date: 2025-12-16 @ 1:20 PM
Study NCT ID: NCT06351592
Status: None
Last Update Posted: 2025-09-17 00:00:00
First Post: 2024-04-02 00:00:00

Brief Title: First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Sponsor:
Organization: Regeneron Pharmaceuticals

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 42
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: